Attention javascript est désactivé sur votre poste.
Ce site nécessite l'activation de javascript pour fonctionner correctement.
Also learn about Oncodesign Services, dedicated to CRO activities in Drug Discovery
Learn more
Also learn about Oncodesign Services, dedicated to CRO activities in Drug Discovery
Learn more
Our pipeline
Partnering
Our innovation technologies
OncoSNIPER
Nanocyclix
PROMETHE
Investors
Message from the chairman
Regulated information [FR]
Press Release
General Meetings [FR]
About us
Latest news
Our history
Management
Our HR policy
Our CSR approach
FederAidd
Contact us
Posts
Search for:
Pages
About us
Careers
FederAidd
Management
News
Our CSR approach
Our history
Contact us
Home
Investors
Message from the chairman
Regulated information [FR]
Legal notice
Our innovation technologies
Nanocyclix
OncoSNIPER
Theranostics
Our pipeline
Partnering
Personal data policy
Press Release
Thank you for signing up to our newsletter
Thank you for your message.
Archives
September 2023
May 2023
April 2023
February 2023
December 2022
October 2022
September 2022
July 2022
June 2022
March 2022
February 2022
January 2022
October 2021
June 2021
May 2021
September 2020
October 2019
Categories
Financial
(6)
News
(12)
Poster
(3)
Press Release
(15)
Scientific paper
(4)
Uncategorized
(2)